Physician

Michael Vaughn Emerson, MD

According to 2025 Medicare claims, Michael Emerson, MD (NPI: 1649222902) practices ophthalmology in the Minneapolis-St. Paul-Bloomington, MN-WI market, with the plurality of this provider's patient population coming from Ramsey, MN. This provider's primary affiliated billing organization is VITREO RETINAL SURGERY PLLC (NPI: 1891783965; TIN: 411608615) and primary practice location at 56001-4877.

Emerson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 969 traditional Medicare patients, billed 14,393 HCPCS/CPT codes, and received $2,150,917 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 407 prescription claims across 171 beneficiaries totaling $18,428 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $766,004 to $2,150,917. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $18,932 and ending at $18,428. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.2M2015 Medicare payment: $766,004 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $814,067 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $878,995 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $988,690 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,520,888 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,425,373 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,376,955 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,362,705 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,845,588 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,150,917 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157418,121$766,004
20167638,045$814,067
20178218,709$878,995
20187938,967$988,690
20191,11513,720$1,520,888
20201,01112,898$1,425,373
20211,02212,395$1,376,955
20221,04511,010$1,362,705
20231,07912,285$1,845,588
202496914,393$2,150,917

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$17K$34K2015 Drug cost: $18,932 (USD; Tot_Drug_Cst)2016 Drug cost: $25,727 (USD; Tot_Drug_Cst)2017 Drug cost: $26,132 (USD; Tot_Drug_Cst)2018 Drug cost: $27,430 (USD; Tot_Drug_Cst)2019 Drug cost: $23,509 (USD; Tot_Drug_Cst)2020 Drug cost: $28,506 (USD; Tot_Drug_Cst)2021 Drug cost: $33,555 (USD; Tot_Drug_Cst)2022 Drug cost: $26,847 (USD; Tot_Drug_Cst)2023 Drug cost: $32,257 (USD; Tot_Drug_Cst)2024 Drug cost: $18,428 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015132356$18,932
2016174464$25,727
2017191541$26,132
2018188581$27,430
2019155481$23,509
2020167548$28,506
2021168565$33,555
2022189482$26,847
2023205499$32,257
2024171407$18,428

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2081,724$655
67028Injection of drug into eye3741,525$98
92014Established patient complete exam of visual system426482$82
92012Established patient problem focused exam of visual system473873$68
92134Imaging of retina9442,464$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate2079,983$11,460
Ketorolac TromethamineKetorolac Tromethamine853,128$2,116
EplerenoneEplerenone271,860$1,790
Atropine SulfateAtropine Sulfate17692$460
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat211,885$262

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Michael Vaughn Emerson, MD?

Tedicare shows public-source Medicare data for Michael Vaughn Emerson, MD (NPI 1649222902), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Vaughn Emerson, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael Vaughn Emerson, MD?

Michael Vaughn Emerson, MD is linked to VITREO RETINAL SURGERY PLLC (billing NPI 1891783965) in the available physician profile data.

Does Michael Vaughn Emerson, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.